Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 37/75 ]
NASDAQ | Common Stock
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.
The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.
It sells its products through direct sales force, sales agents, and independent distributors.
The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jan 22, 26 | -0.46 Decreased by -6.98% | -0.44 Decreased by -3.46% |
| Nov 4, 25 | -0.49 Increased by +14.04% | -0.50 Increased by +2.00% |
| Aug 4, 25 | -0.57 Increased by +12.31% | -0.52 Decreased by -9.62% |
| May 8, 25 | -0.53 Increased by +49.04% | -0.57 Increased by +7.02% |
| Feb 4, 25 | -0.43 Increased by +2.27% | -0.38 Decreased by -13.16% |
| Oct 29, 24 | -0.57 Decreased by -32.56% | -0.47 Decreased by -21.28% |
| Jul 29, 24 | -0.65 Decreased by -16.07% | -0.55 Decreased by -18.18% |
| Apr 30, 24 | -1.04 Decreased by -89.09% | -0.54 Decreased by -92.59% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 16.02 M Increased by +4.45% | -11.93 M Decreased by -12.05% | Decreased by -74.48% Decreased by -7.28% |
| Sep 30, 25 | 14.69 M Increased by +9.85% | -12.87 M Increased by +1.75% | Decreased by -87.61% Increased by +10.56% |
| Jun 30, 25 | 13.59 M Increased by +15.09% | -14.74 M Decreased by -5.04% | Decreased by -108.44% Increased by +8.73% |
| Mar 31, 25 | 12.35 M Increased by +14.65% | -13.77 M Increased by +37.95% | Decreased by -111.48% Increased by +45.88% |
| Dec 31, 24 | 15.34 M Increased by +35.71% | -10.65 M Decreased by -16.24% | Decreased by -69.42% Increased by +14.35% |
| Sep 30, 24 | 13.37 M Increased by +27.23% | -13.10 M Decreased by -45.37% | Decreased by -97.95% Decreased by -14.26% |
| Jun 30, 24 | 11.81 M Increased by +24.28% | -14.03 M Decreased by -20.41% | Decreased by -118.82% Increased by +3.12% |
| Mar 31, 24 | 10.77 M Increased by +34.98% | -22.19 M Decreased by -95.06% | Decreased by -206.00% Decreased by -44.51% |